PHENAZOPYRIDINE HYD

The Defense Logistics Agency awarded DMS PHARMACEUTICAL GROUP INC with CAGE code 1UNB0 a firm-fixed-price contract under solicitation SPE2DP26F7708 for the delivery of one unit of PHENAZOPYRIDINE HYD identified by NSN 6505001388461 at a total price of $452.30, with the award issued on July 15, 2026. This delivery is executed under the umbrella of prior contract SPE2DX25D9900, and the sole line item includes no option quantities or variance allowances, with a strict 0.00% tolerance for quantity deviation. The item must be delivered by July 30, 2026, to Fort Stewart, Georgia, under FOB destination terms, meaning the contractor bears all risk and responsibility for delivery, including compliance with packaging and marking requirements. Each package must be labeled with the full delivery address, the CAGE code, the NDC part number, and the traceable identifier W33RBS61950331, and must be shipped using the fastest traceable means, explicitly prohibiting parcel post. The contract does not specify compliance with any particular MIL-STD or pharmaceutical standard beyond general DoD procurement protocols, but the inclusion of medical substitution rankings and NDC data implies adherence to Defense Health Agency pharmaceutical guidelines. Inspection and acceptance occur at the final destination, with the contractor responsible for ensuring conformity. The payment terms assign FOB responsibility to the contractor, with no explicit remittance address provided, though the destination location serves as the payment point. The contract contains no identified FAR clauses, special requirements, evaluation factors, or socioeconomic certifications, and there are no attachments, points of contact, or details regarding contracting officer representatives. The acquisition is treated as a straightforward, low-value pharmaceutical supply transaction, prioritizing logistics accuracy and timely delivery over complex administrative or technical evaluation criteria.